Deanna Maria Deleon, LPCC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 1005 Ream Avenue, Mt Shasta, CA 96067 Phone: 530-423-5044 Fax: 530-440-7910 |
News Archive
Ambit Biosciences Corporation announced today that there will be multiple presentations evaluating AC220, a novel second generation FLT3 inhibitor, in AML at the 51st American Society of Hematology Annual Meeting (ASH) to be held in New Orleans, LA ,December 5-8, 2009. An oral presentation will highlight results from an ongoing clinical Phase I monotherapy safety study in adults with acute myeloid leukemia (AML).
The electrophysiology team at the Montreal Heart Institute (MHI) recently performed the first implantation of a new type of cardiac pacemaker (Accent RF(TM)) in Canada.
ADVENTRX Pharmaceuticals, Inc. today announced the results of stability tests performed on samples of ANX-530 (vinorelbine injectable emulsion), or Exelbineâ„¢, manufactured at the Company's intended commercial manufacturing site.
Neurotransmitters have consequences. They initiate events that are critical to a healthy life, giving us the ability to move, to talk, to breathe, to think. But that's if the neurotransmitters are getting it right and sending proper signals downstream to muscle cells, neurons or other cells.
Amilpar, the largest managed care organization in Brazil, in accordance with article 157, paragraph 4, of Law 6,404/76 (Brazilian Corporate Law) and CVM Instruction no. 358/02, informs its shareholders and the market that its subsidiary Amil Assistencia Medica Internacional Ltda. ("Applicant") acquired, in the Public Offer auction (Tag Along) for the acquisition of common shares issued by Medial Saude S.A.
› Verified 3 days ago